Lendlease Corporation Limited (ASX:LLC) Reports 1H25 Results
Lendlease Corporation (ASX:LLC) reports strong 1H25 results with significant operational progress and improved profitability.
BlueScope Steel Limited (ASX:BSL) Reports H1 FY2025 Financial Results
BlueScope Steel Limited (ASX:BSL) reports a 7% drop in H1 FY2025 sales, declares a 30c fully franked interim dividend, and extends its share buy-back program.
The a2 Milk Company (ASX:A2M) Announces 1H25 Results and Dividend
The a2 Milk Company (ASX:A2M) reports 1H25 revenue growth of 10.1% and declares an interim dividend of 8.5 NZ cents per share.
The Calmer Co International Limited (ASX:CCO) Secures $2.6m FJD Loan for Navua Facility Acquisition
The Calmer Co (ASX:CCO) secures a $2.6m FJD loan for acquiring its Navua facility, enhancing its operational capabilities.
Swoop Holdings Limited (ASX:SWP) Extends Takeover Offer for Vonex Limited
Swoop Holdings Limited (ASX:SWP) extends its off-market takeover offer for Vonex Limited until 21 February 2025.
Matsa Resources Limited (ASX:MAT) Receives Final Payment from Lake Rebecca Gold Project Sale
Matsa Resources Limited (ASX:MAT) finalizes the partial sale of its Lake Rebecca Gold Project, receiving a total of $1.192 million from Ramelius Resources.
Bulletin Resources Limited (ASX:BNR) Receives Final Payment from Partial Sale
Bulletin Resources Limited (ASX:BNR) receives final $0.8M from partial sale of Lake Rebecca Gold Project, strengthening its financial position.
Eumundi Group (ASX:EBG) Completes Acquisition by SEQ Hospitality Group
Eumundi Group (ASX:EBG) completes acquisition by SEQ Hospitality Group, with shareholders receiving A$1.62 per share and board changes.
Norwood Systems (ASX:NOR) Extends Cash Drawdown Facility
Norwood Systems (ASX:NOR) extends its cash drawdown facility to $732k, securing better terms and an extended repayment date.
Avecho Biotechnology Limited (ASX:AVE) Addresses Recent Securities Trading
Avecho Biotechnology Limited (ASX:AVE) addresses recent securities trading, citing potential Phase III trial success and confirms compliance with ASX listing rules.